Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00071539
Status:
COMPLETED
Last Update Posted:
2012-01-20
First Post:
2003-10-28
Brief Title:
Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
Sponsor:
Teva Branded Pharmaceutical Products RD Inc
Organization:
Teva Branded Pharmaceutical Products RD Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent Glioblastoma Multiforme |
Keywords:
| Name | View |
|---|---|
| gross total resection | View |